|
|
Anne Moscona
J Clin Invest. 2005;
115(7):1688
doi:10.1172/JCI25669
Abstract |
Full text
| PDF
H
uman parainfluenza viruses cause several serious respiratory diseases in children for which there is no effective prevention or therapy. Parainfluenza viruses initiate infection by binding to cell surface receptors and then, via coordinated action of the 2 viral surface glycoproteins, fuse directly with the cell membrane to release the viral replication machinery into the host cell’s cytoplasm. During this process, the receptor-binding molecule must trigger the viral fusion protein to mediate fusion and entry of the virus into a cell. This review explores the binding and entry into cells of parainfluenza virus type 3, focusing on how the receptor-binding molecule triggers the fusion process. There are several steps during the process of binding, triggering, and fusion that are now understood at the molecular level, and each of these steps represents potential targets for interrupting infection.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(14)
| Title and authors |
Publication |
Year |
Cough reflex sensitivity is increased in guinea pigs with parainfluenza virus infection
X. M. Ye, N. S. Zhong, C. L. Liu, R. C. Chen
|
Exp Lung Res
|
2011 |
Detailed genetic analysis of hemagglutinin-neuraminidase glycoprotein gene in human parainfluenza virus type 1 isolates from patients with acute respiratory infection between 2002 and 2009 in Yamagata prefecture, Japan
Katsumi Mizuta, Mika Saitoh, Miho Kobayashi, Hiroyuki Tsukagoshi, Yoko Aoki, Tatsuya Ikeda, Chieko Abiko, Noriko Katsushima, Tsutomu Itagaki, Masahiro Noda
|
Virol J
|
2011 |
Neuraminidase-deficient Sendai virus HN mutants provide protection from homologous superinfection.
Christine A Baumann, Wolfgang J Neubert
|
Arch Virol
|
2010 |
A single amino acid mutation at position 170 of human parainfluenza virus type 1 fusion glycoprotein induces obvious syncytium formation and caspase-3-dependent cell death
M. Takaguchi, T. Takahashi, C. Hosokawa, H. Ueyama, K. Fukushima, T. Hayakawa, K. Itoh, K. Ikeda, T. Suzuki
|
Journal of Biochemistry
|
2010 |
Antiviral effect of strictinin on influenza virus replication
Repon Kumer Saha, Tadanobu Takahashi, Yuuki Kurebayashi, Keijo Fukushima, Akira Minami, Noriaki Kinbara, Masaki Ichitani, Yuko M. Sagesaka, Takashi Suzuki
|
Antiviral Research
|
2010 |
Integrin alphavbeta1 promotes infection by human metapneumovirus.
Gabriella Cseke, Melissa S Maginnis, Reagan G Cox, Sharon J Tollefson, Amy B Podsiad, David W Wright, Terence S Dermody, John V Williams
|
Proc. Natl. Acad. Sci. U.S.A.
|
2009 |
Glycoprotein interactions in paramyxovirus fusion.
Ronald M Iorio, Vanessa R Melanson, Paul J Mahon
|
Future Virology
|
2009 |
Aurintricarboxylic acid inhibits influenza virus neuraminidase
Hui-Chen Hung, Ching-Ping Tseng, Jinn-Moon Yang, Yi-Wei Ju, Sung-Nain Tseng, Yen-Fu Chen, Yu-Sheng Chao, Hsing-Pang Hsieh, Shin-Ru Shih, John T.-A. Hsu
|
Antiviral Research
|
2009 |
Integrative Medicine for Children
May Loo
|
Integrative Medicine for Children
|
2009 |
Inhibition of human parainfluenza virus type 3 infection by novel small molecules.
Hongxia Mao, Chandar S Thakur, Santanu Chattopadhyay, Robert H Silverman, Andrei Gudkov, Amiya K Banerjee
|
Antiviral Research
|
2008 |
|